KZR
Kezar Life Sciences Inc
0.175$
+6.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | -1,166.4% | – | – | |
| – | – | – | – | – | – | – | 15.2% | – | – | |
| – | – | – | – | – | – | – | 259.1% | – | – | |
| – | – | – | – | – | – | – | 67.2% | – | – | |
| – | – | – | – | – | – | – | 25.9% | – | – | |
| – | – | – | – | – | – | – | 1,086.4% | – | – | |
| – | – | – | – | – | – | – | 0.0% | – | – | |
| – | – | – | – | – | – | – | 9.1% | – | – | |
| – | – | – | – | – | – | – | -70.9% | – | – | |
| – | – | – | – | – | – | – | -1,192.2% | – | – |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.